Literature DB >> 8334892

Ultrasound evaluation of ovarian activity under oral contraceptives.

H J Hoogland1, S O Skouby.   

Abstract

The trend towards changing the composition of the contraceptive pill in order to decrease side effects might lead to increased ovarian activity. This may decrease reliability. Therefore, a non-invasive method for monitoring the suppressive effect of the pill on ovarian function is warranted. The aim of the present study was to investigate whether or not diagnostic ultrasound might be the method of choice for studying residual ovarian activity during pill use. In 89 women on a low-dose oral contraceptive (30 mcg ethinyl-estradiol (EE)/75 mcg gestodene), the first two months of pill-intake were monitored extensively with diagnostic ultrasound. The study revealed that only one ultrasound investigation was needed during the first week of pill intake to discover all relevant cases of residual ovarian activity. Follow-up investigations are needed to quantify this activity more specifically.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods--side effects; Denmark; Developed Countries; Ethinyl Estradiol--side effects; Europe; Family Planning; Genitalia; Genitalia, Female; Gestodene--side effects; Measurement; Methodological Studies; Netherlands; Northern Europe; Oral Contraceptives, Low-dose--side effects; Oral Contraceptives--side effects; Ovary; Pearl's Formula; Physiology; Prospective Studies; Reliability; Research Methodology; Scandinavia; Studies; Ultrasonics; Urogenital System; Use-effectiveness; Western Europe

Mesh:

Substances:

Year:  1993        PMID: 8334892     DOI: 10.1016/0010-7824(93)90025-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  19 in total

1.  Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth Rose Mayeda; Kelsey Petrie; Tiffany Thomas; Monica Dragoman; Serge Cremers
Journal:  Am J Obstet Gynecol       Date:  2012-04-28       Impact factor: 8.661

2.  Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use.

Authors:  Kelsey A Petrie; Anu H Torgal; Carolyn L Westhoff
Journal:  Contraception       Date:  2011-06-16       Impact factor: 3.375

Review 3.  Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.

Authors:  M I Wilde; J A Balfour
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 4.  Long-cycle treatment with oral contraceptives.

Authors:  Inka Wiegratz; Herbert Kuhl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill.

Authors:  Maurizio Guida; Giuseppe Bifulco; Attilio Di Spiezio Sardo; Mariamaddalena Scala; Loredana Maria Sosa Fernandez; Carmine Nappi
Journal:  Int J Womens Health       Date:  2010-08-24

Review 6.  Vaginal ring delivery of selective progesterone receptor modulators for contraception.

Authors:  Jeffrey T Jensen
Journal:  Contraception       Date:  2012-10-04       Impact factor: 3.375

Review 7.  Ovarian follicular development during the use of oral contraception: a review.

Authors:  Angela R Baerwald; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2004-01

Review 8.  Estradiol valerate/dienogest: in oral contraception.

Authors:  Sheridan M Hoy; Lesley J Scott
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

9.  Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception.

Authors:  Donna Harrison; Cara Buskmiller; Monique Chireau; Lester A Ruppersberger; Patrick P Yeung
Journal:  Linacre Q       Date:  2019-01-03

10.  Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study.

Authors:  Alison Edelman; Agnes Hemon; Mitchell Creinin; Pascale Borensztein; Bruno Scherrer; Anna Glasier
Journal:  JMIR Res Protoc       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.